The Report Global Combined Hormonal Contraceptives (CHC) Market: Trends and Opportunities (2014-19) provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz
Albany, NY -- (SBWIRE) -- 02/02/2015 -- The report titled "Global Combined Hormonal Contraceptive (CHC) Market: Trends and Opportunities (2014-2019)" provides an in-depth analysis of the global CHC market with detailed analysis of market sizing and growth, market share and economic impact of the industry. The report also assesses key opportunities in the market and outlines the factors that are and will be driving growth of the industry. Growth of the overall CHC industry has also been forecasted for the period 2014-19, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. An insight into strategic issues affecting key brands on the market is provided followed by an analysis of the leading companies in the hormonal contraceptives market. The report also analyzes the key CHC products in pipeline.Further, key players of the industry like Agile Therapeutics; Bayer Healthcare; Teva Pharmaceuticals and Actavis PLC; are analyzed in the report.
View Full Report at http://www.marketresearchreports.biz/analysis/242913
- Country Coverage
- United states
- United Kingdom
- Company Coverage
- Agile Therapeutics Inc.
- Actavis Plc.
- Bayer Healthcare
- Teva Pharmaceuticals
Combined Hormonal Contraceptives (CHC) is widely being used as an effective and reversible birth control method. Mainly used for preventing pregnancies but sometimes also used for treating acne vulgaris, endometriosis, polycystic ovarian syndrome and irregular menstrual flow, CHC works by preventing ovulation i.e. release of egg from ovaries. The hormones are provided in the combined pill, patch or ring.
Download Detail Report With Complete TOC at http://www.marketresearchreports.biz/sample/sample/242913
Most popular Combined Hormonal Contraceptives products are Nuvaring and Ortho Evra. CHC products are broadly used throughout the world by women in the age-group of 15 to 49 years. With increasing health consciousness and awareness, adoption of CHC products or birth control methods is increasing in lesser privileged economic segments too. The growth of CHC market is driven by urbanization and increasing user awareness, rise in menstruating population globally and initiatives taken by governments to encourage the use of contraception. Major trends prevailing in the market are the increasing number of mergers and acquisitions in this business space and demand for reversible method of contraception with fewer side effects.
Table Of Contents
1. EXECUTIVE SUMMARY
2. COMBINED HORMONAL CONTRACEPTIVES MARKET: AN OVERVIEW
2.3.1 Combined Oral Contraceptive Pills
2.3.2 Combined Vaginal Rings
2.3.3 Combined Transdermal Patches
2.3.4 Combined Injectable Birth Control
2.3.5 Combined Emergency Contraceptive Pills
2.4 Mechanism of Action
2.5 Components of CHCs
2.6 Advantages of Combined Hormonal Contraceptives
2.7 Disadvantages of Combined Hormonal Contraceptives
2.9 Serious Risks
3. COMBINED HORMONAL CONTRACEPTIVES(CHC) MARKET ANALYSIS
3.1 Global CHC Market Sizing and Growth
3.2 Global CHC Market Breakup: Branded vs. Generic
3.3 CHC Generic Market
3.4 Global CHC Branded Market
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
Office: State Tower
90 Sate Street, Suite 700
Albany, NY 12207
USA: Canada Toll Free: 866-997-4948